NEMOLIZUMAB-ILTO for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 11 adverse event reports in the FDA FAERS database where NEMOLIZUMAB-ILTO was used for Psoriasis.
Most Reported Side Effects for NEMOLIZUMAB-ILTO
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Inappropriate schedule of product administration | 826 | 19.8% | 0 | 7 |
| Product dose omission issue | 792 | 18.9% | 0 | 12 |
| Device malfunction | 761 | 18.2% | 0 | 1 |
| Incorrect dose administered | 579 | 13.8% | 0 | 1 |
| Pruritus | 416 | 10.0% | 0 | 9 |
| Rash | 263 | 6.3% | 1 | 5 |
| Headache | 181 | 4.3% | 0 | 3 |
| Drug ineffective | 158 | 3.8% | 0 | 2 |
| Device leakage | 153 | 3.7% | 0 | 1 |
| Device use issue | 120 | 2.9% | 0 | 0 |
| Dermatitis atopic | 117 | 2.8% | 0 | 0 |
| Neurodermatitis | 109 | 2.6% | 0 | 2 |
| Eczema | 108 | 2.6% | 0 | 0 |
| Dry skin | 105 | 2.5% | 0 | 1 |
| Erythema | 88 | 2.1% | 0 | 5 |
Other Indications for NEMOLIZUMAB-ILTO
Neurodermatitis (1,765)
Dermatitis atopic (1,596)
Product used for unknown indication (658)
Eczema (99)
Pruritus (30)
Dermatitis (7)
Rash (5)
Urticaria (5)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)